levocabastine
0 sources
levocabastine
Summary
levocabastine is a type of chemical entity[1]. levocabastine has Wikipedia articles in 9 language editions, a strong signal of global cultural recognition.[2]
Key Facts
- levocabastine's instance of is recorded as type of chemical entity[3].
- levocabastine's canonical SMILES is recorded as N#CC1(CCC(CC1)N2CCC(C(C2)C)(C(=O)O)C3=CC=CC=C3)C4=CC=C(C=C4)F[4].
- levocabastine's chemical formula is recorded as C₂₆H₂₉FN₂O₂[5].
- levocabastine is a type of cabastine[6].
- levocabastine is used for medication[7].
- levocabastine's Commons category is recorded as Levocabastine[8].
- levocabastine's NCI Thesaurus ID is recorded as C61806[9].
- levocabastine's different from is recorded as (3S,4R)-1-[4-cyano-4-(4-fluorophenyl)cyclohexyl]-3-methyl-4-phenyl-4-piperidinecarboxylic acid[10].
- levocabastine's isomeric SMILES is recorded as C[C@@H]1CN(CC[C@]1(C(O)=O)C2=CC=CC=C2)[C@H]3CCC@(C#N)C4=CC=C(F)C=C4C@(C#N)C4=CC=C(F)C=C4">[11].
- levocabastine's mass is recorded as {'unit': 'Q483261', 'amount': '+420.2213'}[12].
- levocabastine's medical condition treated is recorded as giant papillary conjunctivitis[13].
- levocabastine's World Health Organisation international non-proprietary name is recorded as {'lang': 'en', 'text': 'levocabastine'}[14].
- levocabastine's subject has role is recorded as H1 antagonist[15].
- levocabastine's subject has role is recorded as non-sedating histamine H1 antagonist[16].
- levocabastine's stereoisomer of is recorded as cabastine[17].
- levocabastine's stereoisomer of is recorded as (3S,4R)-1-[4-cyano-4-(4-fluorophenyl)cyclohexyl]-3-methyl-4-phenyl-4-piperidinecarboxylic acid[18].
- levocabastine's pregnancy category is recorded as Australian pregnancy category B3[19].
- levocabastine's pregnancy category is recorded as US pregnancy category C[20].
- levocabastine's defined daily dose is recorded as {'unit': 'Q3241121', 'amount': '+0.6'}[21].
Why It Matters
levocabastine has Wikipedia articles in 9 language editions, a strong signal of global cultural recognition.[2]